|
COPYRIGHT 2004 Thomson Financial Inc.
The Food and Drug Administration has okayed a tactic that brand-name companies are increasingly using to discourage generic competitors from challenging patents.
By statute, the first generic company that successfully challenges a brand-name patent gets a 180-day period of "marketing exclusivity," during which only it can market a generic...
Read the full article for free courtesy of your local library.
|